| Dr Steven Wayne Sukin, MD | |
|
506 Graham Dr, Ste 150, Tomball, TX 77375-3366 | |
| (281) 351-5174 | |
| (281) 351-5172 |
| Full Name | Dr Steven Wayne Sukin |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 28 Years |
| Location | 506 Graham Dr, Tomball, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154309516 | NPI | - | NPPES |
| P00464640 | Other | TX | MEDICARE RAILROAD ID |
| P00998374 | Other | TX | RAILROAD MEDICARE |
| 742211363 | Other | TX | TAX ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | L3491 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Methodist The Woodlands Hospital | The woodlands, TX | Hospital |
| Houston Methodist Willowbrook Hospital | Houston, TX | Hospital |
| Hca Houston Healthcare Tomball | Tomball, TX | Hospital |
| Houston Methodist West Hospital | Houston, TX | Hospital |
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights.
There is evidence that selective serotonin reuptake inhibitor antidepressants can promote neuronal cell proliferation and enhance neuroplasticity both in vitro and in vivo.
A.D.A.M., Inc., a leading provider of health information and benefit technology solutions, today announced its financial results for the fourth quarter ended December 31, 2009.
The U.S. Food and Drug Administration today approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.
› Verified 9 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights.
There is evidence that selective serotonin reuptake inhibitor antidepressants can promote neuronal cell proliferation and enhance neuroplasticity both in vitro and in vivo.
A.D.A.M., Inc., a leading provider of health information and benefit technology solutions, today announced its financial results for the fourth quarter ended December 31, 2009.
The U.S. Food and Drug Administration today approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Wayne Sukin, MD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Dr Steven Wayne Sukin, MD 506 Graham Dr, Ste 150, Tomball, TX 77375-3366 Ph: (281) 351-5174 |
News Archive
OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights.
There is evidence that selective serotonin reuptake inhibitor antidepressants can promote neuronal cell proliferation and enhance neuroplasticity both in vitro and in vivo.
A.D.A.M., Inc., a leading provider of health information and benefit technology solutions, today announced its financial results for the fourth quarter ended December 31, 2009.
The U.S. Food and Drug Administration today approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.
› Verified 9 days ago
Matthew M Hogan, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 919 Graham Dr, Tomball, TX 77375 Phone: 281-516-6530 Fax: 281-290-9824 | |
Dr. Penner T Schraudenbach, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 506 Graham Dr Ste 150, Tomball, TX 77375 Phone: 281-351-5174 Fax: 281-351-5172 | |
Liliana Woo, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 919 Graham Dr, Tomball, TX 77375 Phone: 281-516-6530 Fax: 281-290-9824 | |
Dr. Miguel Angel Mercado, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 506 Graham Dr Ste 150, Tomball, TX 77375 Phone: 281-351-5174 Fax: 281-381-5172 | |
Jerry D Rouse, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 13414 Medical Complex Dr, Ste. 13, Tomball, TX 77375 Phone: 281-351-8229 | |
Dr. Clyde Leland Corey, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 919 Graham Dr, Tomball, TX 77375 Phone: 281-516-6530 Fax: 281-290-9824 |